| Q33825736 | 17α-estradiol attenuates neuron loss in ovariectomized Dtg AβPP/PS1 mice. |
| Q39711842 | 2,2',4'-trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice |
| Q43197086 | A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis. |
| Q34527792 | A comparative evaluation of treatments with 17β-estradiol and its brain-selective prodrug in a double-transgenic mouse model of Alzheimer's disease |
| Q48229419 | A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin-D detection |
| Q30455082 | APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). |
| Q34218993 | Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics. |
| Q99624207 | Acetylation of AMPA Receptors Regulates Receptor Trafficking and Rescues Memory Deficits in Alzheimer's Disease |
| Q92532068 | Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model |
| Q28771517 | Activation of nicotinic α7 acetylcholine receptor enhances long term potentation in wild type mice but not in APPswe/PS1ΔE9 mice |
| Q34096125 | Adipose-derived mesenchymal stem cell transplantation promotes adult neurogenesis in the brains of Alzheimer's disease mice. |
| Q37813299 | Ageing and protein aggregation-mediated disorders: from invertebrates to mammals |
| Q38126026 | Aging, protein aggregation, chaperones, and neurodegenerative disorders: mechanisms of coupling and therapeutic opportunities |
| Q30493543 | Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease |
| Q49524953 | Alzheimer's Disease Mutant Mice Exhibit Reduced Brain Tissue Stiffness Compared to Wild-type Mice in both Normoxia and following Intermittent Hypoxia Mimicking Sleep Apnea |
| Q35156207 | Aminostyrylbenzofuran directly reduces oligomeric amyloid-β and reverses cognitive deficits in Alzheimer transgenic mice |
| Q38843285 | Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice |
| Q34982983 | Amyloid β-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide |
| Q34414740 | An anterograde rabies virus vector for high-resolution large-scale reconstruction of 3D neuron morphology |
| Q47355534 | An exploratory investigation of brain-selective estrogen treatment in males using a mouse model of Alzheimer's disease |
| Q47244184 | Anesthetic Isoflurane or Desflurane Plus Surgery Differently Affects Cognitive Function in Alzheimer's Disease Transgenic Mice |
| Q30572684 | Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline |
| Q37061262 | Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice |
| Q44328454 | Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance |
| Q60949629 | Assessment of spatial learning and memory in the Barnes maze task in rodents-methodological consideration |
| Q48901829 | Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice |
| Q34074699 | Barnes maze testing strategies with small and large rodent models |
| Q37395530 | Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment |
| Q40053117 | Behavioural effects of PNU-282987 and stress in an animal model of Alzheimer's disease. |
| Q40625519 | Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance. |
| Q41444056 | Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice |
| Q50472663 | Cholinergic Modification of Neurogenesis and Gliosis Improves the Memory of AβPPswe/PSEN1dE9 Alzheimer's Disease Model Mice Fed a High-Fat Diet. |
| Q35827454 | Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration |
| Q47794929 | Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice |
| Q48431434 | Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon. |
| Q90587999 | Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis |
| Q36997908 | Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease |
| Q42544187 | Cox-2 Plays a Vital Role in the Impaired Anxiety Like Behavior in Colchicine Induced Rat Model of Alzheimer Disease |
| Q46655961 | Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease |
| Q36717090 | Deficits in hippocampal-dependent transfer generalization learning accompany synaptic dysfunction in a mouse model of amyloidosis |
| Q36582377 | Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice |
| Q47351358 | Detection of β-Amyloid by Sialic Acid Coated Bovine Serum Albumin Magnetic Nanoparticles in a Mouse Model of Alzheimer's Disease |
| Q35589042 | Differential proteomic and behavioral effects of long-term voluntary exercise in wild-type and APP-overexpressing transgenics. |
| Q59758209 | Direct reprogramming of fibroblasts into neural stem cells by single non-neural progenitor transcription factor Ptf1a |
| Q93166438 | Discovery of nitazoxanide-based derivatives as autophagy activators for the treatment of Alzheimer's disease |
| Q37458204 | Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels |
| Q51759819 | Dynamic SAP102 expression in the hippocampal subregions of rats and APP/PS1 mice of various ages. |
| Q50422373 | Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease. |
| Q51038505 | Early temporal short-term memory deficits in double transgenic APP/PS1 mice |
| Q37154745 | Effects of an alpha7 nicotinic receptor agonist and stress on spatial memory in an animal model of Alzheimer's disease |
| Q36953692 | Elevated oxidative stress and sensorimotor deficits but normal cognition in mice that cannot synthesize ascorbic acid |
| Q28247764 | Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model |
| Q90441714 | Ellagic acid ameliorates learning and memory impairment in APP/PS1 transgenic mice via inhibition of β-amyloid production and tau hyperphosphorylation |
| Q43152844 | Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks |
| Q36019557 | Enhanced penetration of exogenous EPCs into brains of APP/PS1 transgenic mice |
| Q30420041 | Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss |
| Q50034406 | Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology. |
| Q48753034 | Expression of δNp73 in hippocampus of APP/PS1 transgenic mice following GFP-BMSCs transplantation |
| Q21133775 | Galactic cosmic radiation leads to cognitive impairment and increased aβ plaque accumulation in a mouse model of Alzheimer's disease |
| Q92072136 | Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice |
| Q92363257 | High Dietary Iron Disrupts Iron Homeostasis and Induces Amyloid-β and Phospho-τ Expression in the Hippocampus of Adult Wild-Type and APP/PS1 Transgenic Mice |
| Q55262808 | Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition. |
| Q39457273 | Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice |
| Q51013962 | Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease. |
| Q47102588 | Intermittent Fasting Protects against Alzheimer's Disease Possible through Restoring Aquaporin-4 Polarity |
| Q50719528 | Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice. |
| Q34110890 | Intracranial V. cholerae sialidase protects against excitotoxic neurodegeneration |
| Q37235613 | Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice |
| Q35621563 | Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease |
| Q37693458 | Intravenous ascorbate improves spatial memory in middle-aged APP/PSEN1 and wild type mice. |
| Q47771892 | Kalirin reduction rescues psychosis-associated behavioral deficits in APPswe/PSEN1dE9 transgenic mice |
| Q46158936 | Low-dose proton radiation effects in a transgenic mouse model of Alzheimer's disease - Implications for space travel. |
| Q36715856 | MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function |
| Q30823245 | Measuring discrimination- and reversal learning in mouse models within 4 days and without prior food deprivation. |
| Q53413215 | Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease. |
| Q47280341 | Mesenchymal Stem Cell-Derived Extracellular Vesicles Suppresses iNOS Expression and Ameliorates Neural Impairment in Alzheimer's Disease Mice |
| Q30419141 | Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice |
| Q93129413 | Minor ginsenoside F1 improves memory in APP/PS1 mice |
| Q90718217 | Mossy cell synaptic dysfunction causes memory imprecision via miR-128 inhibition of STIM2 in Alzheimer's disease mouse model |
| Q46912904 | NAD attenuates oxidative DNA damages induced by amyloid beta-peptide in primary rat cortical neurons |
| Q36579852 | Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease |
| Q33768246 | Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. |
| Q36465116 | Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer's disease |
| Q46185330 | Neuroprotective Effect of Ligustilide through Induction of α-Secretase Processing of Both APP and Klotho in a Mouse Model of Alzheimer's Disease |
| Q47098610 | Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice |
| Q89999010 | Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice |
| Q35101132 | Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: implications for translational research. |
| Q61796294 | Opposing Roles of apolipoprotein E in aging and neurodegeneration |
| Q37213608 | Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice |
| Q34299310 | Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease. |
| Q26747019 | Palmitoylation in Alzheimer's disease and other neurodegenerative diseases |
| Q51021977 | Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice. |
| Q37220808 | Progesterone reduces depression-like behavior in a murine model of Alzheimer's Disease |
| Q28551173 | Protective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's Disease |
| Q30423207 | Pyrrolidine dithiocarbamate attenuates brain Aβ increase and improves long-term neurological outcome in rats after transient focal brain ischemia |
| Q44968491 | RETRACTED: Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer's disease mouse model. |
| Q57192805 | RPS23RG1 Is Required for Synaptic Integrity and Rescues Alzheimer's Disease-Associated Cognitive Deficits |
| Q30497845 | Reduced IGF-1 signaling delays age-associated proteotoxicity in mice |
| Q89640703 | Retinal analysis of a mouse model of Alzheimer's disease with multicontrast optical coherence tomography |
| Q93035932 | Revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging |
| Q24601406 | SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. |
| Q26784170 | Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline |
| Q92714088 | Small interfering RNA delivery to the neurons near the amyloid plaques for improved treatment of Alzheimer׳s disease |
| Q36115392 | Small molecule LX2343 ameliorates cognitive deficits in AD model mice by targeting both amyloid β production and clearance |
| Q34489284 | Smart Soup, a traditional Chinese medicine formula, ameliorates amyloid pathology and related cognitive deficits |
| Q35612961 | Spatial and nonspatial escape strategies in the Barnes maze |
| Q39577346 | Spectral unmixing imaging of wavelength-responsive fluorescent probes: an application for the real-time report of amyloid Beta species in Alzheimer's disease |
| Q49361337 | Subtle Alterations in Spatial Memory Induced by Amyloid Peptides Infusion in Rats. |
| Q89813314 | Synergic Effects of Berberine and Curcumin on Improving Cognitive Function in an Alzheimer's Disease Mouse Model |
| Q53081269 | Targeting glucocorticoid receptors prevents the effects of early life stress on amyloid pathology and cognitive performance in APP/PS1 mice. |
| Q28833244 | Targeting the γ-/β-secretase interaction reduces β-amyloid generation and ameliorates Alzheimer's disease-related pathogenesis |
| Q49804395 | The Cyanthin Diterpenoid and Sesterterpene Constituents of Hericium erinaceus Mycelium Ameliorate Alzheimer's Disease-Related Pathologies in APP/PS1 Transgenic Mice |
| Q59806753 | The Emerging Role of Altered Cerebellar Synaptic Processing in Alzheimer's Disease |
| Q48785645 | The Synergistic Roles of the Chronic Prenatal and Offspring Stress Exposures in Impairing Offspring Learning and Memory |
| Q46342780 | The diphenylpyrazole compound anle138b blocks Aβ channels and rescues disease phenotypes in a mouse model for amyloid pathology. |
| Q90086183 | The expanding phenotypes of cohesinopathies: one ring to rule them all! |
| Q39497033 | The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits |
| Q42503378 | Therapeutic effects of human amniotic epithelial cell transplantation on double-transgenic mice co-expressing APPswe and PS1ΔE9-deleted genes. |
| Q28550590 | Traditional Chinese Nootropic Medicine Radix Polygalae and Its Active Constituent Onjisaponin B Reduce β-Amyloid Production and Improve Cognitive Impairments |
| Q36950042 | Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis |
| Q38956724 | Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia. |
| Q33828868 | Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice |
| Q34418781 | Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models |
| Q35764820 | Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice |
| Q33688727 | Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice |
| Q37301622 | Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice |
| Q28534524 | Vitamin D2-enriched button mushroom (Agaricus bisporus) improves memory in both wild type and APPswe/PS1dE9 transgenic mice |
| Q48284096 | Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease. |
| Q33715454 | YXQN Reduces Alzheimer's Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice |